PORTFOLIO COMPANIES


Blue Belt Technologies





prior investment

HealthpointCapital is a values-driven, research-based private equity firm
exclusively focused on the musculoskeletal sector — specifically orthopedics and dental. HealthpointCapital manages in excess of $800 million of institutional capital.

Orthopedic & Dental Industry Research Most Recent Blog Articles

DePuy Synthes Announces Agreement with Blue Belt Technologies, Inc. Agreement enables access to the SIGMA HP Partial Knee on the Navio Surgical System BY EDITOR, SEPTEMBER 17, 2014

DePuy Synthes, the world's largest provider of orthopaedic and neurological solutions, announced today a worldwide commercial agreement with Blue Belt Technologies, a global medical technology company specializing in enabling technologies for orthopaedic surgery. The agreement will enable orthopaedic surgeons to... more

Danaher to Acquire Nobel Biocare for $2.2B BY ANDREW VAHRADIAN, SEPTEMBER 15, 2014

Danaher Corporation entered into an agreement to acquire the Zürich, Switzerland-based Nobel Biocare, the second largest dental implant developer, in an all cash transaction valued at an enterprise value of $2.2 billion, or 3.0x LTM revenues, or 16.0x LTM EBITDA.... more

Musculoskeletal News Roundup 12-Sep-14 BY ANDREW VAHRADIAN, SEPTEMBER 12, 2014

Orchid Orthopedic receives grant...ArchiMed acquires MediStream...Cerapedics files PMA...EOS, Mazor Robotics, Trice medical receive product approval...Titan Spine announces warranty...Tyber Medical launches product...CartiHeal, Ceterix Orthopaedics receive patents...Reliance Medical, Smith & Nephew suit updates...Cellular Biomedicine, IMPLANET clinical trial updates...EU creates €1.0 billion ($1.3 billion) fund for research on the use of graphene...Medical device recall report...Geisinger launches three orthopedic programs...Proception Medical enters license agreement for the development of two extremity devices...VEXIM opens U.S. subsidiary...Aurora Spine appointments more

Researchers Reveal Nasal Septum Cells’ Ability to Treat Articular Cartilage Defects BY ANDREW VAHRADIAN, SEPTEMBER 12, 2014

A team of researchers at the University and the University Hospital of Basel, revealed that cartilage cells extracted from the nasal septum, called nasal chondrocytes, not only are able to adapt to the environment of the knee joint, but also... more

Complete Archive »


Search the HealthpointCapital Site